A new study provides a comprehensive catalogue of the genetic changes in Wilms tumour. Understanding the interplay between genetic and epigenetic aberrations during tumorigenesis and clonal evolution is fundamental to enabling prediction of who is at risk and which tumours will relapse when so many are curable.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dome, J. S. et al. Children's Oncology Group's 2013 blueprint for research: renal tumors. Pediatr. Blood Cancer 60, 994–1000 (2013).
Brok, J., Treger, T. D., Gooskens, S. L., van den Heuvel-Eibrink, M. M. & Pritchard-Jones, K. Biology and treatment of renal tumours in childhood. Eur. J. Cancer 68, 179–195 (2016).
Torrezan, G. T. et al. Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour. Nat. Commun. 5, 4039 (2014).
Walz, A. L. et al. Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors. Cancer Cell 27, 286–297 (2015).
Wegert, J. et al. Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors. Cancer Cell 27, 298–311 (2015).
Gadd, S. et al. A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor. Nat. Genet. 49, 1487–1494 (2017).
Cresswell, G. D. et al. Intra-tumor genetic heterogeneity in Wilms tumor: clonal evolution and clinical implications. EBioMedicine 9, 120–129 (2016).
Scott, R. H. et al. Stratification of Wilms tumor by genetic and epigenetic analysis. Oncotarget 3, 327–335 (2012).
Charles, A. K., Brown, K. W. & Berry, P. J. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development. Am. J. Pathol. 153, 991–1000 (1998).
Scott, R. H. et al. Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. Nat. Genet. 40, 1329–1334 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Mifsud, W., Pritchard-Jones, K. Integrating genomics to dig deeper into Wilms tumour biology. Nat Rev Urol 14, 703–704 (2017). https://doi.org/10.1038/nrurol.2017.178
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2017.178
This article is cited by
-
Wilms tumour
Nature Reviews Disease Primers (2021)
-
The effectiveness of Wilms tumor screening in Beckwith–Wiedemann spectrum
Journal of Cancer Research and Clinical Oncology (2019)
-
Reply to Brioude et al
European Journal of Human Genetics (2018)